Neo43: You are wrong. Mr. wunderlich told me that he never discusses who and what shares are owned by any stockholders. Big B has been altering the truth again. The only interest the Bunker Hunt investment group had was a loan with CYGX years ago. They also got the right to 10% of the licensing revenue if and when it happened. They obviously have written off CYGX and got all that CyGX could afford to pay. That's where the magical $25,000 value came from. After years of press releases with no progress beyond the pre-clinical level their patience ran out. It rellay comes bakc to the delivery problem. Whether it thru cream on the skin, areosol in the lungs or direct input into the cell CYGx just can't get enough material to completely stop any disease.